Algonomics

About:

Algonomics provides structural bioinformatics services to develop rationally designed therapeutics in the field of immunotherapy.

Website: http://www.algonomics.com

Top Investors: VIB, Gemma Frisius Fund, Baekeland Funds, TrustCapital

Description:

AlgoNomics is a Belgium based biotech company providing structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains innovative tools to unravel protein-protein and protein-peptide interactions. AlgoNomics' premier product is the Epibase® platform for T-cell epitope identification in different population groups, applied in the discovery of vaccines and therapeutic proteins.